The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersonal Group Regulatory News (PGH)

Share Price Information for Personal Group (PGH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 162.50
Bid: 160.00
Ask: 165.00
Change: 0.00 (0.00%)
Spread: 5.00 (3.125%)
Open: 162.50
High: 162.50
Low: 162.50
Prev. Close: 162.50
PGH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TR-1: Notification of Major Interest in Shares

2 Dec 2016 07:00

RNS Number : 7635Q
Personal Group Holdings PLC
02 December 2016
 

 

For filings with the FCA include the annex

For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Personal Group Holdings plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

x

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Delta Lloyd N.V. and its Group of Companies

4. Full name of shareholder(s)  (if different from 3.):iv

Registered Holder:

 

Delta Lloyd L European Participation Fund Sicav

 

749,411

 

Delta Lloyd Europees Deelnemingen Fonds N.V.

 

1,402,568

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

30 November 2016

6. Date on which issuer notified:

1 December 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

7% at combined indirect interest level

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary shares

2,151,979

2,151,979

2,151,979

NIHIL

2,151,979

NIHIL

6.99%

GB0002760279

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

2,151,979

6.99%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

The voting rights held in the 2 investment funds are managed and controlled by Delta Lloyd Asset Management N.V., with the following chain of controlled undertakings:

 

Delta Lloyd Asset Management N.V.:

· Delta Lloyd N.V.

· DLAM Holding B.V. (wholly owned subsidiary of Delta Lloyd N.V.)

· Delta Lloyd Asset Management N.V. (wholly owned subsidiary of DLAM Holding B.V.)

Proxy Voting:

10. Name of the proxy holder:

See section 4

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

Figures are based on a change in the outstanding shares:

30,594,098 (30 November 2016)

to

30,799,891 (1 December 2016)

14. Contact name:

M. Koster, Senior Product manager

15. Contact telephone number:

+31 20 59 43691

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLTBBPTMBTMBFF
Date   Source Headline
22nd Apr 20247:00 amRNSPurchase of shares by Employee Benefit Trust
18th Apr 20242:56 pmRNSPurchase of shares by Employee Benefit Trust
11th Apr 20249:28 amRNSDirector/PDMR Shareholding
5th Apr 202411:00 amRNSNotice of AGM
5th Apr 20247:00 amRNSGrant of LTIP & CSOP Options
20th Mar 20248:00 amRNSReplacement:Preliminary Results and Final Dividend
19th Mar 20247:01 amRNSGlobal Airline Selects Personal Group
19th Mar 20247:00 amRNSPreliminary Results and Final Dividend
14th Mar 20247:00 amRNSNotice of Results Presentations
25th Jan 20247:00 amRNSTrading Update and Notice of Results
17th Jan 20242:21 pmRNSDirector/PDMR Dealings
4th Jan 20245:38 pmRNSPDMR Share Dealing
18th Dec 20234:25 pmRNSDirector/PDMR Dealings
13th Dec 20234:48 pmRNSHolding(s) in Company
29th Nov 202310:37 amRNSChange of Nominated Adviser and Broker
29th Sep 20237:00 amRNSInterim Results
25th Sep 20237:00 amRNSNotification of Major Holdings
4th Sep 20237:00 amRNSNotice of Results
10th Aug 20236:09 pmRNSGrant of LTIP options
19th Jul 20233:40 pmRNSTrading Update & Update on CEO Transition-Amend
19th Jul 20237:00 amRNSTrading Update and Update on CEO Transition
10th Jul 20231:42 pmRNSPDMR Share Dealing
21st Jun 20237:00 amRNSGrant of LTIP & CSOP options
4th May 202311:30 amRNSResults of Annual General Meeting
4th May 202311:18 amRNSNotification of Major Holdings
4th May 20237:01 amRNSAGM Statement
4th May 20237:00 amRNSCEO Succession
21st Apr 20232:32 pmRNSAGM Notification Amendment
11th Apr 20233:36 pmRNSAGM Notification
28th Mar 20237:00 amRNSPreliminary Results and Final Dividend
13th Mar 20237:00 amRNSNotice of Results Presentations
30th Jan 20237:00 amRNSTrading Update
4th Jan 20232:33 pmRNSPDMR Share Dealing
27th Sep 20227:00 amRNSInterim Results
19th Aug 20227:00 amRNSNotice of Analyst and Investor Presentations
26th Jul 20227:00 amRNSTrading Update and Notice of Results
5th Jul 20227:00 amRNSPDMR Share Dealing
1st Jul 20227:00 amRNSAcquisition of Quintige Consulting Group Limited
16th Jun 20227:00 amRNSDirector's Dealings
9th Jun 20229:32 amRNSExercise of Share Options, PDMR Dealings and TVR
1st Jun 20227:00 amRNSDirectorate Change
24th May 20227:00 amRNSDirectorate Change
5th May 20225:00 pmRNSResults of Annual General Meeting
5th May 20227:00 amRNSAGM Statement
20th Apr 20227:00 amRNSLong Term Incentive Plan Awards
12th Apr 202211:06 amRNSAGM Notification
4th Apr 20227:00 amRNSPurchase of shares by Employee Benefit Trust
29th Mar 20227:00 amRNSPreliminary Results and Final Dividend
2nd Mar 20227:00 amRNSAppointment of Chief Wellbeing Ambassador
28th Feb 20223:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.